VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GALT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GALTGalectin Therapeutics Inc.
$2.98$196M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGALTQuarterly Cash Flow

Galectin Therapeutics Inc. (GALT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Galectin Therapeutics Inc. (GALT) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

GALT Cash Flow Statement

Quarterly statement

GALT Cash Flow Statement

Galectin Therapeutics Inc. (GALT) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-2.27M-2.44M-3.87M-6.04M-3.54M-6.6M-7.69M-12.79M-8.54M-8.33M-12.11M-4.7M-7.64M-9.83M-10.79M-7.24M-8.35M-7.43M-8.04M-6.95M
Operating CF Margin %--------------------
Operating CF Growth %36.05%63.06%49.72%52.76%58.51%20.77%36.48%-172.03%-11.8%15.25%-12.16%35.05%8.51%-32.38%-34.21%-4.14%-67.01%-24.28%-26.01%-28.39%
Net Income-3.53M-9.11M-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M
Depreciation & Amortization30K4K12K41K02K10K10K9K9K9K9K8K032K8K7K7K10K11K
Stock-Based Compensation949K963K686K195K496K500K468K590K515K738K604K497K586K0662K681K681K647K858K654K
Deferred Taxes00000000000000000000
Other Non-Cash Items4.09M3.21M-827K403K2.42M1.45M372K-1.75M1.04M141K1.08M-145K682K179K913K-143K342K-197K-149K-204K
Working Capital Changes-3.8M2.49M1.31M-1.18M1.73M-1.03M1.09M326K1.11M3.15M-2.31M4.93M1.51M-898K-873K2.85M-780K1.73M1.17M-191K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables-271K662K-662K-2.46M-345K-2.72M-522K-521K-173K1.91M-3.29M5.08M621K-1.66M-1.37M3.35M-1.25M1.28M864K669K
Cash from Investing00000000000000000000
Capital Expenditures00000000000000000000
CapEx % of Revenue--------------------
Acquisitions00000000000000000000
Investments--------------------
Other Investing00000000000000000000
Cash from Financing702K1.6M257K12.24M1.3M12.94M0851K10M10.38M10M10M10.03M10M10M10M00010M
Debt Issued (Net)00010M011M0010M10M10M-20M010M10M10M00010M
Equity Issued (Net)01.6M257K2.24M853K1.94M0851K0376K030M10.03M000000-1K
Dividends Paid-1K0-61K00000000000000000
Share Repurchases00000000000000000000
Other Financing703K061K0443K000000000000000
Net Change in Cash-1.56M-842K-3.61M6.2M-2.25M6.34M-7.69M-11.94M1.46M2.04M-2.1M5.3M2.4M167K-793K2.76M-8.35M-7.43M-8.04M3.05M
Free Cash Flow-2.27M-2.44M-3.87M-6.04M-3.54M-6.6M-7.69M-12.79M-8.54M-8.33M-12.11M-4.7M-7.64M-9.83M-10.79M-7.24M-8.35M-7.43M-8.04M-6.95M
FCF Margin %--------------------
FCF Growth %36.05%63.06%49.72%52.76%58.51%20.77%36.48%-172.03%-11.8%15.25%-12.16%35.05%8.51%-32.38%-34.21%-4.14%-67.01%-24.28%-26.01%-28.39%
FCF per Share-0.03-0.04-0.06-0.09-0.06-0.10-0.12-0.20-0.14-0.13-0.20-0.08-0.13-0.17-0.18-0.12-0.14-0.13-0.14-0.12
FCF Conversion (FCF/Net Income)0.64x0.27x0.77x1.10x0.43x0.88x0.80x1.07x0.76x0.67x1.05x0.47x0.73x1.08x0.94x0.68x0.97x0.77x0.81x0.96x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000